References
- See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA. 2021;325(24):2448–2456. doi:10.1001/jama.2021.7517
- Shay DK, Gee J, Su JR, et al. Safety monitoring of the Janssen (Johnson & Johnson) covid-19 vaccine - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(18):680–684. doi:10.15585/mmwr.mm7018e2
- Brighton Collaboration. Interim case definition of Thrombosis with Thrombocytopenia Syndrome (TTS); 2021. Available from: https://brightoncollaboration.us/thrombosis-with-thrombocytopenia-syndrome-interim-case-definition/. Accessed June 6, 2023.
- Liberman AL, Kamel H, Mullen MT, Messé SR. International classification of diseases, ninth revision (ICD-9) diagnosis codes can identify cerebral venous thrombosis in hospitalized adults. Neurohospitalist. 2016;6(4):147–150. doi:10.1177/1941874416648198
- Handley JD, Emsley HC. Validation of ICD-10 codes shows intracranial venous thrombosis incidence to be higher than previously reported. Health Inf Manag. 2020;49(1):58–61. doi:10.1177/1833358318819105
- Liao SC, Shao SC, Lai EC, Lin SJ, Huang WI, Hsieh CY. Positive predictive value of ICD-10 codes for cerebral venous sinus thrombosis in taiwan’s national health insurance claims database. Clin Epidemiol. 2022;14:1–7. doi:10.2147/clep.S335517
- FDA Center for Biologics Evaluation and Research. COVID-19 vaccine safety surveillance: active monitoring master protocol; 2021. Available from: https://www.bestinitiative.org/wp-content/uploads/2021/02/C19-Vaccine-Safety-Protocol-2021.pdf. Accessed June 3, 2023.